skip to Main Content

Leading Edge Technology for Pathogen Detection

At Y2X Life Sciences, we believe there is an urgent need for new technologies that combat and control infectious diseases

Since 2000, the world has experienced more than 74 pandemics and epidemics, including COVID-19, SARS, MERS, Ebola, and Swine Flu

Yet, there has been no significant innovation in technologies to detect and prevent the spread of infectious diseases in over 30 years

Leading-Edge Technologies to Detect Aerosolized Pathogens

  • Signed Options Agreement: Technology developed by WashU that immediately detects SARS-CoV-2 and other pathogens in people and spaces
  • Funded research: Through NIH RADx Initiative Grant
  • Purpose: Create biosensors that substantially reduce large-scale infectious disease testing times and improves aerosolized pathogen detection accuracy in indoor spaces


Y2X Life Sciences actively engages in groundbreaking research and development for disrupting the transmission of infectious diseases.

The result is innovative technologies that bring about faster recoveries from pandemics like Covid-19, and have the potential to limit the scope and spread of future pandemics and epidemics.

Visit the About page to meet our extensive team of Y2X Life Sciences leaders, consultants, and advisors

Read about groundbreaking research and development and cutting edge technologies

Back To Top